Literature DB >> 21072531

Management of punding in Parkinson's disease: an open-label prospective study.

A Fasano1, L Ricciardi, M Pettorruso, A R Bentivoglio.   

Abstract

Punding, a peculiar stereotyped behavior characterized by intense fascination with complex, excessive, non-goal-oriented, repetitive activities, is a quite rare condition complicating Parkinson's disease (PD). It is triggered by dopaminergic therapy and could have a strong impact on patient quality of life. No study has specifically investigated medical management of this condition, and only a few anecdotal reports have provided therapeutic hints. Given the suggested similarities to drug-induced dyskinesias, we have previously suggested a multistep algorithm for management of punding. We conducted a prospective open-label study on ten PD punders aimed at testing its validity. In two cases, reduction of levodopa therapy was efficacious; amantadine was effective in controlling punding in four cases; in the remaining cases, quetiapine was employed, with mild efficacy in two cases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21072531     DOI: 10.1007/s00415-010-5817-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  19 in total

1.  Punding and dyskinesias.

Authors:  Laura Silveira-Moriyama; Andrew H Evans; Regina Katzenschlager; Andrew J Lees
Journal:  Mov Disord       Date:  2006-12       Impact factor: 10.338

Review 2.  The glutamate homeostasis hypothesis of addiction.

Authors:  Peter W Kalivas
Journal:  Nat Rev Neurosci       Date:  2009-07-01       Impact factor: 34.870

Review 3.  Insights into pathophysiology of punding reveal possible treatment strategies.

Authors:  A Fasano; I Petrovic
Journal:  Mol Psychiatry       Date:  2010-06       Impact factor: 15.992

4.  Pathological gambling in Parkinson disease is reduced by amantadine.

Authors:  Astrid Thomas; Laura Bonanni; Francesco Gambi; Angelo Di Iorio; Marco Onofrj
Journal:  Ann Neurol       Date:  2010-09       Impact factor: 10.422

5.  Punding on levodopa.

Authors:  J H Friedman
Journal:  Biol Psychiatry       Date:  1994-09-01       Impact factor: 13.382

6.  Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs.

Authors:  G Rylander
Journal:  Psychiatr Neurol Neurochir       Date:  1972 May-Jun

7.  Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia.

Authors:  Incarnation Aubert; Céline Guigoni; Kerstin Håkansson; Qin Li; Sandra Dovero; Nicole Barthe; Bernard H Bioulac; Christian E Gross; Gilberto Fisone; Bertrand Bloch; Erwan Bezard
Journal:  Ann Neurol       Date:  2005-01       Impact factor: 10.422

8.  Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome.

Authors:  Andrew H Evans; Regina Katzenschlager; Dominic Paviour; John D O'Sullivan; Silke Appel; Andrew D Lawrence; Andrew J Lees
Journal:  Mov Disord       Date:  2004-04       Impact factor: 10.338

Review 9.  Diagnostic criteria for Parkinson disease.

Authors:  D J Gelb; E Oliver; S Gilman
Journal:  Arch Neurol       Date:  1999-01

10.  Stereotyped behaviors or punding after quetiapine administration in Parkinson's disease.

Authors:  Hideto Miwa; Shuhei Morita; Ichiro Nakanishi; Tomoyoshi Kondo
Journal:  Parkinsonism Relat Disord       Date:  2004-03       Impact factor: 4.891

View more
  15 in total

Review 1.  Impulsive and compulsive behaviors in Parkinson's disease.

Authors:  B B Averbeck; S S O'Sullivan; A Djamshidian
Journal:  Annu Rev Clin Psychol       Date:  2013-12-02       Impact factor: 18.561

Review 2.  [Repetitive impulse-associated behavioral disorders in Parkinson's disease].

Authors:  R Katzenschlager; K S Goerlich; T van Eimeren
Journal:  Nervenarzt       Date:  2012-12       Impact factor: 1.214

Review 3.  Neuropsychiatric Issues in Parkinson's Disease.

Authors:  Jeffrey W Cooney; Mark Stacy
Journal:  Curr Neurol Neurosci Rep       Date:  2016-05       Impact factor: 5.081

4.  Psychosis and concurrent impulse control disorder in Parkinson's disease: A review based on a case report.

Authors:  Bruno Fukelmann Guedes; Marcia Rubia Gonçalves; Rubens Gisbert Cury
Journal:  Dement Neuropsychol       Date:  2016 Apr-Jun

Review 5.  Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease.

Authors:  Barbara Connolly; Susan H Fox
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 6.  Therapeutic potential of targeting glutamate receptors in Parkinson's disease.

Authors:  Clare Finlay; Susan Duty
Journal:  J Neural Transm (Vienna)       Date:  2014-02-21       Impact factor: 3.575

7.  Prospective cohort study of impulse control disorders in Parkinson's disease.

Authors:  Jesse Bastiaens; Benjamin J Dorfman; Paul J Christos; Melissa J Nirenberg
Journal:  Mov Disord       Date:  2013-01-02       Impact factor: 10.338

Review 8.  Targeting glutamate receptors to tackle the pathogenesis, clinical symptoms and levodopa-induced dyskinesia associated with Parkinson's disease.

Authors:  Susan Duty
Journal:  CNS Drugs       Date:  2012-12       Impact factor: 5.749

9.  Further characterisation of psychosis-like behaviours induced by L-DOPA in the MPTP-lesioned marmoset.

Authors:  Cynthia Kwan; Stephen G Nuara; Jim C Gourdon; Philippe Huot
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-05-08       Impact factor: 3.000

10.  Diagnosis and treatment of impulse control disorders in patients with movement disorders.

Authors:  Tiago A Mestre; Antonio P Strafella; Teri Thomsen; Valerie Voon; Janis Miyasaki
Journal:  Ther Adv Neurol Disord       Date:  2013-05       Impact factor: 6.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.